Chronometric Administration of Cyclophosphamide and a Double-Stranded DNA-Mix at Interstrand Crosslinks Repair Timing, Called “Karanahan” Therapy, Is Highly Efficient in a Weakly Immunogenic Lewis Carcinoma Model

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	1610180
Journal	Pathology and Oncology Research
Volume	28
DOIs	https://doi.org/10.3389/pore.2022.1610180
Publication status	Published - 27 May 2022

cancer stem cells, committed tumor cells, cytostatic agent, dsDNA, interstrand crosslink repair, Karanahan approach, Lewis lung carcinoma, tumor growth site, Antigens, CD34, Cyclophosphamide/pharmacology, Humans, Mice, Inbred C57BL, Neoplastic Stem Cells/pathology, DNA/genetics, Animals, Carcinoma/pathology, Mice

ID: 36560974